Takada K, Levy G
J Pharm Sci. 1980 Jan;69(1):9-14. doi: 10.1002/jps.2600690104.
The purpose of this investigation was to determine the effect of dose on warfarin pharmacokinetics in rats. First, in a crossover experiment, rats received 14C-warfarin, 0.2 mg/kg iv, 12 hr after an injection of either nonradioactive warfarin (0.5 mg/kg) or saline solution. Warfarin concentrations in plasma declined triexponentially as a function of time. Pharmacokinetic analysis revealed that pretreatment with warfarin significantly decreased the apparent volume of distribution, total plasma clearance, and intrinsic plasma clearance of the drug. In the second part of the investigation, rats received single intravenous warfarin injections in the order of 0.1-1.0-0.1 or 1.0-0.1-1.0 mg/kg at 2-week intervals. The apparent volume of distribution, total plasma clearance, and intrinsic plasma clearance of the 1.0-mg/kg warfarin dose were appreciably lower than those of the 0.1-mg/kg dose. The decrease in the apparent volume of distribution of warfarin with increasing dose is consistent with the previously observed concentration dependence in hepatic uptake of the drug.
本研究的目的是确定剂量对大鼠华法林药代动力学的影响。首先,在一项交叉实验中,大鼠在注射非放射性华法林(0.5 mg/kg)或生理盐水溶液12小时后,静脉注射14C-华法林,剂量为0.2 mg/kg。血浆中华法林浓度随时间呈三相指数下降。药代动力学分析表明,华法林预处理显著降低了该药物的表观分布容积、总血浆清除率和内在血浆清除率。在研究的第二部分,大鼠每隔2周按0.1 - 1.0 - 0.1或1.0 - 0.1 - 1.0 mg/kg的顺序接受单次静脉注射华法林。1.0 mg/kg华法林剂量的表观分布容积、总血浆清除率和内在血浆清除率明显低于0.1 mg/kg剂量。随着剂量增加,华法林表观分布容积的降低与先前观察到的该药物肝脏摄取的浓度依赖性一致。